Spectrophotometric Determination of Risedronate in Pharmaceutical Formulations via Complex Formation with Cu (II) Ions: Application to Content Uniformity Testing

Journal Title: International Journal of Biomedical Science (IJBS) - Year 2008, Vol 4, Issue 4

Abstract

A simple, sensitive, rapid and accurate spectrophotometric method was developed for the determination of risedronate, a bisphosphonate drug important for the treatment of a variety of bone diseases, in raw material and pharmaceutical formulations. The proposed method is based on complex formation between risedronate and Cu (II) ions in acetate buffer of pH5.5. The optimum conditions for this reaction were ascertained and a spectrophotometric method was developed for the determination of risedronate in concentration range of 2-40 µg/mL with detection limit of 0.03 µg/mL (9.51 × 10-8 mol/L). The molar absorbtivity was 8.00 × 103 l/mol/cm. The method was successfully applied for the determination of risedronate in tablet dosage form with mean percentage recovery of 101.04 ± 0.32. The results obtained were favorably compared with those obtained by the comparison method. Furthermore, the proposed method was applied for content uniformity testing of risedronate tablets.

Authors and Affiliations

M. I. Walash, M. E. -S. Metwally, M. Eid, R. N. El-Shaheny

Keywords

Related Articles

Free Radicals, Antioxidants in Disease and Health

Free radicals and oxidants play a dual role as both toxic and beneficial compounds, since they can be either harmful or helpful to the body. They are produced either from normal cell metabolisms in situ or from external...

<br /> Dietary Supplementation of Vitamin E and α-lipoic Acid Upregulates Cell Growth and Signaling Genes in Rat Myocardium

The efficacy of antioxidant supplementation in the prevention of cardiovascular disease appears equivocal, however the use of more potent antioxidant combinations than those traditionally used may exert a more positive e...

Retroperitoneal Hemorrhage from Adrenocortical Carcinoma as a Poor Prognostic Factor

In most patients, adrenocortical carcinoma is diagnosed at an advanced stage of the disease. A sudden retroperitoneal hemorrhage may sometimes be the first symptom of the adrenal cancer. We describe four patients with ad...

HIV/AIDS Knowledge, Attitudes, and Behaviors of Construction Workers in China

The objective of the study was to describe HIV/AIDS knowledge, attitudes, risk behaviors, and sources of information among construction workers in China. A cross-sectional survey of 458 construction workers was conducted...

Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels

Angiogenesis is a complex multistep process that comprises proliferation, migration, and anastomosis of endothelial cells, followed by stabilization of the newly formed vessel through the attachment of support cells. Thi...

Download PDF file
  • EP ID EP82955
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

M. I. Walash, M. E. -S. Metwally, M. Eid, R. N. El-Shaheny (2008). Spectrophotometric Determination of Risedronate in Pharmaceutical Formulations via Complex Formation with Cu (II) Ions: Application to Content Uniformity Testing. International Journal of Biomedical Science (IJBS), 4(4), 303-309. https://europub.co.uk/articles/-A-82955